Witty on GSK’s HGSI bid: ‘We are the compelling owner for this business’

GlaxoSmithKline (NYSE:GSK) stood ready to field questions about its first quarter financial earnings but everyone seemingly wanted to ask CEO Andrew Witty about the pharmaceutical giant’s $2.6 b…
Read the full story: MedCity News